Brokerages predict that Unum Group (NYSE:UNM) will announce $1.35 earnings per share for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Unum Group’s earnings. The highest EPS estimate is $1.37 and the lowest is $1.34. Unum Group reported earnings of $1.30 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 3.8%. The firm is scheduled to report its next earnings results on Monday, July 29th.
According to Zacks, analysts expect that Unum Group will report full-year earnings of $5.44 per share for the current fiscal year, with EPS estimates ranging from $5.40 to $5.50. For the next fiscal year, analysts anticipate that the firm will post earnings of $5.81 per share, with EPS estimates ranging from $5.75 to $5.85. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that that provide coverage for Unum Group.
Unum Group (NYSE:UNM) last released its quarterly earnings results on Tuesday, April 30th. The financial services provider reported $1.31 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.31. The business had revenue of $2.99 billion during the quarter, compared to analysts’ expectations of $2.99 billion. Unum Group had a return on equity of 12.91% and a net margin of 4.54%. The firm’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same period last year, the firm posted $1.24 EPS.
NYSE:UNM opened at $33.55 on Wednesday. The firm has a market cap of $7.11 billion, a PE ratio of 6.45, a P/E/G ratio of 0.66 and a beta of 1.53. The business’s 50 day moving average price is $33.57. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.17 and a current ratio of 0.17. Unum Group has a 1-year low of $26.76 and a 1-year high of $41.28.
In related news, Director Gloria C. Larson sold 1,602 shares of Unum Group stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $33.55, for a total transaction of $53,747.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.49% of the company’s stock.
Large investors have recently added to or reduced their stakes in the stock. BlackRock Inc. raised its holdings in Unum Group by 21.5% in the 4th quarter. BlackRock Inc. now owns 19,837,098 shares of the financial services provider’s stock valued at $582,815,000 after acquiring an additional 3,516,140 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Unum Group by 8.9% in the 4th quarter. Dimensional Fund Advisors LP now owns 4,875,403 shares of the financial services provider’s stock valued at $143,237,000 after acquiring an additional 396,764 shares in the last quarter. Geode Capital Management LLC raised its holdings in Unum Group by 15.1% in the 4th quarter. Geode Capital Management LLC now owns 3,344,324 shares of the financial services provider’s stock valued at $98,111,000 after acquiring an additional 438,390 shares in the last quarter. Northern Trust Corp raised its holdings in Unum Group by 0.7% in the 1st quarter. Northern Trust Corp now owns 2,635,821 shares of the financial services provider’s stock valued at $89,169,000 after acquiring an additional 19,621 shares in the last quarter. Finally, Norges Bank acquired a new position in Unum Group in the 4th quarter valued at $70,966,000. 91.35% of the stock is owned by institutional investors and hedge funds.
About Unum Group
Unum Group, together with its subsidiaries, provides financial protection benefit solutions in the United States, the United Kingdom, and internationally. It operates through Unum US, Unum UK, Colonial Life, and Closed Block segments. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.
Recommended Story: Guidelines for Successful Channel Trading
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Unum Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unum Group and related companies with MarketBeat.com's FREE daily email newsletter.